title: [Melanoma cell lines as the basis for antitumor vaccine preparation].
abstract: The aim of the study was to obtain cell lines from tumor samples, and to determine phenotypic cell characteristics in order to choose the optimal line for vaccine preparation. 15 cell lines with stable growth, varying in cultural growth character and cytomorphology, were obtained from samples taken from patients with metastatic skin melanoma. Immunofluorescense method was used to determine the expression of T- and B-lymphocyte markers, antigens of major histocompatibility complex (MHC) class I and II, and CD86 co-stimulating molecule in the cell lines. The expression of melanocyte differentiation antigens and cancer/testicular antigens was evaluated using immunocytochemical assay. The results allowed the authors to distinguish three types of melanoma cell lines according to the expression of MHC molecules: MHC-negative; MHC class I positive; MHC classes I and II positive.
authors.forename: I N
authors.initials: IN
authors.lastname: Mikhaĭlova
authors.forename: M I
authors.initials: MI
authors.lastname: Lukashina
authors.forename: A Iu
authors.initials: AIu
authors.lastname: Baryshnikov
authors.forename: L F
authors.initials: LF
authors.lastname: Morozova
authors.forename: O S
authors.initials: OS
authors.lastname: Burova
authors.forename: T N
authors.initials: TN
authors.lastname: Palkina
authors.forename: A M
authors.initials: AM
authors.lastname: Kozlov
authors.forename: V A
authors.initials: VA
authors.lastname: Golubeva
authors.forename: E A
authors.initials: EA
authors.lastname: Cheremushkin
authors.forename: M B
authors.initials: MB
authors.lastname: Doroshenko
authors.forename: L V
authors.initials: LV
authors.lastname: Demidov
authors.forename: S L
authors.initials: SL
authors.lastname: Kiselev
authors.forename: S S
authors.initials: SS
authors.lastname: Larin
authors.forename: G P
authors.initials: GP
authors.lastname: Georgiev
mesh_terms: D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000138:chemical synthesis*; D045744:Cell Line, Tumor; D006801:Humans; D008544:Melanocytes / Q000276:immunology; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D010641:Phenotype; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*
chemical_list: D000951:Antigens, Neoplasm; D019496:Cancer Vaccines